ArticleAmerican journal of translational research2025

Efficacy and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma patients.

Xufei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.